These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 16991031)

  • 21. Cardiac device therapy 1: theory, technology and terminology.
    Modi S; Rao A; Hughes S; Ramsdale D
    Br J Hosp Med (Lond); 2008 Nov; 69(11):620-4. PubMed ID: 19069261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Device therapy for the management of advanced heart failure.
    Krishnamani R; DeNofrio D
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):573-80. PubMed ID: 15225116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What is the level of evidence for combined cardiac resynchronization and defibrillation therapy in heart failure?
    Lam SK; Owen A
    Eur Heart J; 2008 Mar; 29(5):682-3; author reply 683-4. PubMed ID: 18310672
    [No Abstract]   [Full Text] [Related]  

  • 24. Cardiac resynchronisation therapy for the treatment of heart failure: NICE technology appraisal guidance.
    Barnett D; Phillips S; Longson C
    Heart; 2007 Sep; 93(9):1134-5. PubMed ID: 17699177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resynchronizing ventricular contraction in heart failure.
    Jarcho JA
    N Engl J Med; 2005 Apr; 352(15):1594-7. PubMed ID: 15829542
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiac resynchronization therapy in heart failure patients: an update.
    Jeevanantham V; Daubert JP; Zareba W
    Cardiol J; 2009; 16(3):197-209. PubMed ID: 19437393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cardioverter-defibrillator (ICD) and resynchronization in every patient with cardiac failure--For].
    Klein HU
    Dtsch Med Wochenschr; 2006 Apr; 131(14):772. PubMed ID: 16596499
    [No Abstract]   [Full Text] [Related]  

  • 28. Cardiac resynchronization therapy--who benefits? Separating myths from facts.
    Deshpande S; Tol S; Lokhandwala Y
    Indian Heart J; 2007; 59(1 Suppl A):A57-62. PubMed ID: 19104133
    [No Abstract]   [Full Text] [Related]  

  • 29. Frontiers in congestive heart failure: initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy.
    Tepper D
    Congest Heart Fail; 2002; 8(2):91. PubMed ID: 11927784
    [No Abstract]   [Full Text] [Related]  

  • 30. Prognostic value of renal function in patients with cardiac resynchronization therapy.
    Fung JW; Szeto CC; Chan JY; Zhang Q; Chan HC; Yip GW; Yu CM
    Int J Cardiol; 2007 Oct; 122(1):10-6. PubMed ID: 17174419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cardiac resynchronization therapy: are all questions answered?].
    Auricchio A
    Herzschrittmacherther Elektrophysiol; 2005 Mar; 16(1):1-2. PubMed ID: 15824869
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardiac-resynchronization therapy for heart failure.
    Hare JM
    N Engl J Med; 2002 Jun; 346(24):1902-5. PubMed ID: 12063376
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of left ventricular lead position on clinical outcomes in the COMPANION study: does placement really matter?
    Freedberg NA
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):769-72. PubMed ID: 19460075
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiac resynchronization therapy for heart failure: has the time come?
    Yancy CW; Filardo G
    Circulation; 2009 Feb; 119(7):916-8. PubMed ID: 19237670
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardiac resynchronization therapy in New York Heart Association class IV heart failure: it is all about selection.
    Tang WH; Francis GS
    Circulation; 2007 Jan; 115(2):161-2. PubMed ID: 17228011
    [No Abstract]   [Full Text] [Related]  

  • 36. Advances in cardiac pacing. New indications and technology.
    Barold SS; Stroobandt RX
    Acta Cardiol; 2003 Apr; 58(2):101-17. PubMed ID: 12715902
    [No Abstract]   [Full Text] [Related]  

  • 37. Upgrading to biventricular pacing/defibrillation systems in right ventricular paced congestive heart failure patients: prospective assessment of procedural parameters and response rate.
    Duray GZ; Israel CW; Pajitnev D; Hohnloser SH
    Europace; 2008 Jan; 10(1):48-52. PubMed ID: 18077483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of new pacemaker and defibrillator technology.
    Shepard RB; Epstein AE; Kay GN
    Adv Card Surg; 1994; 5():181-208. PubMed ID: 8118592
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cardiac insufficiency and electric stimulation of the heart].
    Adamec R; Barthélémy JC
    Ther Umsch; 1984 Feb; 41(2):131-3. PubMed ID: 6710423
    [No Abstract]   [Full Text] [Related]  

  • 40. Major regression of severe mitral regurgitation in an adult with congenital heart disease and cardiac resynchronization therapy.
    Thambo JB; Bordachar P; Lafitte S; Clementy J
    Europace; 2007 Dec; 9(12):1184. PubMed ID: 17550905
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.